The mini paddle apparatus– A useful tool in the early developmental stage? Experiences with immediate-release dosage forms

Dissolution Technologies

Volumn 13, Issue 4, 2006, Pages 6-11

  Klein, Sandra ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCHLOROTHIAZIDE; INDOMETACIN; METOPROLOL TARTRATE; THEOPHYLLINE;

ANALYTICAL PARAMETERS; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DOSAGE FORM; DRUG RELEASE; DRUG SOLUBILITY; GENERAL DEVICE; HYDRODYNAMICS; IN VITRO STUDY; MINI PADDLE APPARATUS; NOTE; STIRRING SPEED;

EID: 84962061517     PISSN: 1521298X     EISSN: None     Source Type: Journal    
DOI: 10.14227/DT130406P6     Document Type: Note

References (15)

1. Dissolution Testing of Immediate Release Solid Oral Dosage Forms; Guidance for Industry; U. S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), U. S. Government Printing Office: Washington, DC, 1997.
2. Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System; Guidance for Industry; U. S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), U. S. Government Printing Office: Washington, DC, 2000.
3. Scholz, A.; Kostewicz, E.; Abrahamsson, B.; Dressman, J. B. Can the USP paddle method be used to represent invivo hydrodynamics? J. Pharm. Pharmacol. 2003, 55 (4), 443-451.
4. Wu, Y.; Kildsig, D. O.; Ghaly, E. S. Effect of hydrodynamic environment on tablets dissolution rate. Pharm. Dev. Technol. 2004, 9 (1), 25-37.
5. Diebold, S. Physiological Parameters Relevant to Dissolution Testing: Hydrodynamic Considerations. In Pharmaceutical Dissolution Testing; Dressman, J., Kraemer, J., Eds.; Taylor & Francis: Boca Raton, FL, 2005; pp 127-191.
6. Lindenberg, M.; Kopp, S.; Dressman, J. B. Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system. Eur. J. Pharm. Biopharm. 2004, 58 (2), 265-278.
7. Kasim, N. A.; Whitehouse, M.; Ramachandran, C.; Bermejo, M.; Lennernas, H.; Hussain, A. S.; Junginger, H. E.; Stavchansky, S. A.; Midha, K. K.; Shah, V. P.; Amidon, G. Molecular Properties of WHO Essential Drugs and Provisional Biopharmaceutical Classification. Mol. Pharm. 2004, 1 (1), 85-96.
8. Wu, C. Y.; Benet, L. Z. Predicting drug disposition via application of BCS: Transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm. Res. 2005, 22 (1), 11-23.
9. Moore, J. W.; Flanner, H. H. Mathematical comparison of dissolution profiles. Pharm. Technol. 1996, 20, 64-74.
10. Shah, V. P.; Tsong, Y.; Sathe, P.; Williams, R. L. Dissolution profile comparison using similarity factor, f2. Dissolution Technol. 1999, 6 (3), 15.
11. Shah, V. P.; Tsong, Y.; Sathe, P.; Liu, J. P. In vitro dissolution profile comparison-statistics and analysis of the similarity factor, f2. Pharm. Res. 1998, 15 (6), 889-896.
12. Extended Release Oral Dosage Forms: Development, Evaluation, and Application of In Vitro/In Vivo Correlations; Guidance for Industry; U. S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), U. S. Government Printing Office: Washington, DC, 1997.
13. SUPAC-MR: Modified Release Solid Oral Dosage Forms. Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls; In Vitro Dissolution Testing and In Vivo Bioequivalence Documentation; Guidance for Industry; U. S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), U. S. Government Printing Office: Washington, DC, 1997.
14. Oral Extended (Controlled) Release Dosage Forms In Vivo Bioequivalence and In Vitro Dissolution Testing; Guidance for Industry; U. S. Department of Health and Human Services, Food and Drug Administration, Office of Generic Drugs, U. S. Government Printing Office: Washington, DC, 1993.
15. Mirza, T.; Yatindra, J.; Qian, J. L.; Vivilecchia, R. Evaluation of Dissolution Hydrodynamics in the USP, Peak™ and Flat- Bottom Vessels Using Different Solubility Drugs. Dissolution Technol. 2005, 12 (1), 11-16.